These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 12081016

  • 1. Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide.
    Vázquez Blomquist D, Green P, Laidlaw SM, Skinner MA, Borrow P, Duarte CA.
    Viral Immunol; 2002; 15(2):337-56. PubMed ID: 12081016
    [Abstract] [Full Text] [Related]

  • 2. Effect of promoters on cellular immune response induced by recombinant fowlpox virus expressing multi-epitope polypeptides from HIV-1.
    Vázquez-Blomquist D, González S, Duarte CA.
    Biotechnol Appl Biochem; 2002 Dec; 36(3):171-9. PubMed ID: 12452800
    [Abstract] [Full Text] [Related]

  • 3. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE, Abaitua F, Rodríguez D, Esteban M.
    Virus Res; 2004 Sep 15; 105(1):11-22. PubMed ID: 15325077
    [Abstract] [Full Text] [Related]

  • 4. Modified-vaccinia-virus-Ankara (MVA) priming and fowlpox-virus booster elicit a stronger CD8+ T-cell response in mice against an HIV-1 epitope than does a DNA/poxvirus prime-booster approach.
    Vázquez-Blomquist D, Quintana D, Duarte CA.
    Biotechnol Appl Biochem; 2004 Jun 15; 39(Pt 3):313-8. PubMed ID: 15154843
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH, Tuskan RG, Lewis GK.
    AIDS Res Hum Retroviruses; 2001 Jun 10; 17(9):819-27. PubMed ID: 11429123
    [Abstract] [Full Text] [Related]

  • 6. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector.
    Gómez CE, Rodríguez D, Rodríguez JR, Abaitua F, Duarte C, Esteban M.
    Vaccine; 2001 Dec 12; 20(5-6):961-71. PubMed ID: 11738764
    [Abstract] [Full Text] [Related]

  • 7. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H, Wakabayashi A, Shimizu M, Kaneko H, Norose Y, Nakagawa Y, Wang J, Kumagai Y, Margulies DH, Takahashi H.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):356-63. PubMed ID: 15020225
    [Abstract] [Full Text] [Related]

  • 8. The HIV-1 chimeric protein CR3 expressed by poxviral vectors induces a diverse CD8+ T cell response in mice and is antigenic for PBMCs from HIV+ patients.
    Vázquez-Blomquist D, Iglesias E, González-Horta EE, Duarte CA.
    Vaccine; 2003 Dec 12; 22(2):145-55. PubMed ID: 14615141
    [Abstract] [Full Text] [Related]

  • 9. Construction and characterization of a recombinant fowlpox virus containing HIV-1 multi-epitope-p24 chimeric gene in mice.
    Zhang L, Jin N, Song Y, Wang H, Ma H, Li Z, Jiang W.
    Sci China C Life Sci; 2007 Apr 12; 50(2):212-20. PubMed ID: 17447028
    [Abstract] [Full Text] [Related]

  • 10. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
    Nakagawa Y, Shimizu M, Norose Y, Takahashi M, Takahashi H.
    Int Immunol; 2013 Jan 12; 25(1):11-24. PubMed ID: 22945875
    [Abstract] [Full Text] [Related]

  • 11. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
    Wang X, Uto T, Akagi T, Akashi M, Baba M.
    J Virol; 2007 Sep 12; 81(18):10009-16. PubMed ID: 17609261
    [Abstract] [Full Text] [Related]

  • 12. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D, Puaux AL, Rivière Y, Michel ML.
    Immunobiology; 2005 Sep 12; 210(5):305-19. PubMed ID: 16164038
    [Abstract] [Full Text] [Related]

  • 13. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
    Casement KS, Nehete PN, Arlinghaus RB, Sastry KJ.
    Virology; 1995 Aug 01; 211(1):261-7. PubMed ID: 7645219
    [Abstract] [Full Text] [Related]

  • 14. The multi-epitope polypeptide approach in HIV-1 vaccine development.
    Cano CA.
    Genet Anal; 1999 Nov 01; 15(3-5):149-53. PubMed ID: 10596755
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
    Hanke T, Blanchard TJ, Schneider J, Ogg GS, Tan R, Becker M, Gilbert SC, Hill AV, Smith GL, McMichael A.
    J Gen Virol; 1998 Jan 01; 79 ( Pt 1)():83-90. PubMed ID: 9460927
    [Abstract] [Full Text] [Related]

  • 16. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.
    Hum Immunol; 2004 May 01; 65(5):514-22. PubMed ID: 15172452
    [Abstract] [Full Text] [Related]

  • 17. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
    Negri DR, Buffa V, Leone P, Bona R, Borghi M, Carlini F, De Angelis F, Indraccolo S, Ensoli B, Cara A.
    J Immunol Methods; 2004 Aug 01; 291(1-2):153-63. PubMed ID: 15345313
    [Abstract] [Full Text] [Related]

  • 18. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ.
    J Immunol; 1997 Jan 15; 158(2):834-41. PubMed ID: 8993001
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R.
    Clin Immunol; 2001 Oct 15; 101(1):51-8. PubMed ID: 11580226
    [Abstract] [Full Text] [Related]

  • 20. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
    Harrington LE, Most Rv Rv, Whitton JL, Ahmed R.
    J Virol; 2002 Apr 15; 76(7):3329-37. PubMed ID: 11884558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.